Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-25 @ 3:21 AM
NCT ID:
NCT00813605
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed adenocarcinoma of colon or rectum in patients with metastatic disease
* Mutant-type KRAS tumor at screening
* Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 - 1
* Adequate hematology, renal, hepatic, and coagulation function
Exclusion Criteria:
* History or known presence of central nervous system metastases
* History of other malignancy
* Prior irinotecan-based chemotherapy for advanced/metastatic disease
* Prior death receptor agonists, or other systemic IGF-1R agonists in any setting
* Uncontrolled cardiovascular disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00813605
Study Brief:
Protocol Section:
NCT00813605